A Thorough Pelvic Lymph Node Dissection in Presence of Positive Margins Associated With Better Clinical Outcomes in Radical Cystectomy Patients

Urology

Volumn 74, Issue 1, 2009, Pages 161-165

  Canter, Daniel ^a   Guzzo, Thomas J ^a   Resnick, Matthew J ^a   Bergey, Meredith R ^b   Sonnad, Seema S ^b   Tomaszewski, John ^a   VanArsdalen, Keith ^a   Malkowicz, S Bruce ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; CANCER PATIENT; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 67649211072     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.024     Document Type: Article

References (24)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
2. Dinney C.P. Therapy of invasive bladder cancer. Urology 67 suppl 1 (2006) 56-61
3. Nieder A.M., MacKinnon J.A., Huang Y., et al. Florida bladder cancer. Trends: 1981 to2004: minimal progress in decreasing advanced disease. J Urol 179 (2008) 491-495
4. Araki M., Nieder A.M., Manoharan M., et al. Lack of progress in early diagnosis of bladder cancer. Urology 69 (2007) 270-274
5. Gofrit O.N., Zorn K.C., Steinberg G.D., et al. Will Rogers phenomenon in urological oncology. J Urol 179 (2007) 28-33
6. Turkolmez K., Tokgoz H., Resorlu B., et al. Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urology 70 (2007) 477-481
7. Herr H.W. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61 (2003) 105-108
8. Bartsch G.C., Kuefer R., Gschwend J.E., et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol 51 (2007) 690-698
9. Habuchi T., Marberger M., Droller M.J., et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66 (2005) 64-74
10. Margel D., Tal R., and Baniel J. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. J Urol 178 (2007) 2297-2301
11. Shariat S.F., Ashfaq R., Sagalowsky A.I., et al. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder. Urol Oncol 25 (2007) 468-475
12. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137-151
13. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95 (2005) 786-790
14. Stojadinovic A., Leung D.H., Allen P., et al. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 20 (2002) 4344
15. Dotan Z.A., Kavanagh K., Yossepowitch O., et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178 (2007) 2308-2313
16. Frazier H.A., Robertson J.E., Dodge R.K., et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71 (1993) 3993-4001
17. Herr H.W., Lee C., Chang S., et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a Collaborative Group report. J Urol 171 (2004) 1823-1828
18. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: a Cooperative Group report. J Clin Oncol 22 (2004) 2781-2789
19. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
20. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J Urol 170 (2003) 35-41
21. Sanderson K.M., Skinner D., and Stein J.P. The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer. Nat Clin Practice Urol 3 (2006) 485-494
22. Stein J.P. Lymphadenectomy in bladder cancer: how high is "high enough"?. Urol Oncol 24 (2006) 349-355
23. Steven K., and Poulsen A.L. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 178 (2007) 1218-1224
24. Dhar N.B., Klein E.A., Reuther A.M., et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179 (2008) 873-878